Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000715812-20-000006
Filing Date
2020-09-10
Accepted
2020-09-10 15:10:35
Documents
43
Period of Report
2020-07-31

Document Format Files

Seq Description Document Type Size
1 bsyn073120.htm 10-Q 178442
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER bsynx311.htm EX-31.1 10137
9 CERTIFICATION OF CHIEF ACCOUNTING OFFICER bsynx312.htm EX-31.2 10326
10 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED bsynx321.htm EX-32.1 6819
11 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED bsynx322.htm EX-32.2 5304
  Complete submission text file 0000715812-20-000006.txt   1236337

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE bsyn-20200701.xml EX-101.INS 149254
3 XBRL SCHEMA FILE bsyn-20200701.xsd EX-101.SCH 16453
4 XBRL CALCULATION FILE bsyn-20200701_cal.xml EX-101.CAL 38287
5 XBRL DEFINITION FILE bsyn-20200701_def.xml EX-101.DEF 20134
6 XBRL LABEL FILE bsyn-20200701_lab.xml EX-101.LAB 117932
7 XBRL PRESENTATION FILE bsyn-20200701_pre.xml EX-101.PRE 89793
Mailing Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603
Business Address 55 WEST MONROE STREET STE 1200 CHICAGO IL 60603 8479560471
BIOSYNERGY INC (Filer) CIK: 0000715812 (see all company filings)

EIN.: 362880990 | State of Incorp.: IL | Fiscal Year End: 0430
Type: 10-Q | Act: 34 | File No.: 000-12459 | Film No.: 201168658
SIC: 3829 Measuring & Controlling Devices, NEC